Wellgistics Health, Inc. - SIC # 8010 -

Ticker Exchange SIC # Website Latest Ticker
WGRX Nasdaq 8010 www.wellgisticshealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Wellgistics Health, Inc.

Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX) - Jul 10th, 2025 9:46 am
Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem - Jun 25th, 2025 5:45 am
Wellgistics Health Joins OptiSource to Expand Access and Drive Savings for Independent Pharmacies - Jun 10th, 2025 5:45 am
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes - May 29th, 2025 5:45 am
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - May 28th, 2025 5:45 am
Wellgistics Health Reports 36% Revenue Growth in Q1 2025 as Manufacturer Access and Pharmacy Onboarding Accelerate - May 12th, 2025 5:40 am
Healthcare firm banks on SEC and Ripple settlement - May 9th, 2025 5:29 pm
Florida Pharma Firm Will Use XRP for Real-Time Payments in $50M Financing Deal - May 9th, 2025 1:26 am
CORRECTION FROM SOURCE: Wellgistics Health Secures $50M ELOC Facility for XRP Treasury Reserve and Real-Time Payments Infrastructure and Other General Ops - May 8th, 2025 7:25 am
Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative - May 8th, 2025 5:05 am
Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network - Apr 30th, 2025 2:25 pm
Wellgistics Names Mark DiSiena as New CFO - Apr 24th, 2025 5:40 am
CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price - Apr 15th, 2025 5:40 am
Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue - Apr 10th, 2025 5:40 am
Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025 - Mar 27th, 2025 6:05 am
Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models - Mar 18th, 2025 5:40 am
Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure - Mar 4th, 2025 3:18 pm
Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™ - Mar 4th, 2025 5:40 am
Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market - Feb 26th, 2025 5:40 am
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering - Feb 25th, 2025 11:15 am